A detailed history of Villere St Denis J & CO LLC transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Villere St Denis J & CO LLC holds 366,967 shares of CLGN stock, worth $1.82 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
366,967
Previous 361,293 1.57%
Holding current value
$1.82 Million
Previous $2.31 Million 14.95%
% of portfolio
0.17%
Previous 0.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$4.72 - $6.15 $26,781 - $34,895
5,674 Added 1.57%
366,967 $1.96 Million
Q4 2023

Jan 25, 2024

BUY
$4.97 - $6.64 $1.8 Million - $2.4 Million
361,293 New
361,293 $2.31 Million
Q3 2023

Oct 20, 2023

BUY
$5.4 - $8.05 $1.62 Million - $2.42 Million
300,173 New
300,173 $1.67 Million
Q2 2023

Jul 18, 2023

BUY
$6.6 - $8.23 $19,311 - $24,080
2,926 Added 1.01%
292,723 $2.39 Million
Q1 2023

Apr 25, 2023

BUY
$6.74 - $12.99 $17,861 - $34,423
2,650 Added 0.92%
289,797 $2.03 Million
Q4 2022

Jan 18, 2023

BUY
$4.71 - $9.5 $4,474 - $9,025
950 Added 0.33%
287,147 $2.4 Million
Q3 2022

Oct 17, 2022

BUY
$6.87 - $9.99 $132,591 - $192,807
19,300 Added 7.23%
286,197 $1.95 Million
Q2 2022

Jul 18, 2022

BUY
$8.0 - $11.19 $7,200 - $10,071
900 Added 0.34%
266,897 $2.14 Million
Q1 2022

Apr 19, 2022

BUY
$8.97 - $16.4 $81,851 - $149,650
9,125 Added 3.55%
265,997 $2.98 Million
Q4 2021

Jan 19, 2022

BUY
$12.0 - $22.48 $104,664 - $196,070
8,722 Added 3.51%
256,872 $4.2 Million
Q3 2021

Oct 19, 2021

BUY
$16.0 - $21.75 $14,400 - $19,575
900 Added 0.36%
248,150 $4.19 Million
Q2 2021

Jul 19, 2021

BUY
$13.55 - $22.45 $3.35 Million - $5.55 Million
247,250 New
247,250 $5.24 Million

Others Institutions Holding CLGN

About CollPlant Biotechnologies Ltd


  • Ticker CLGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,086,500
  • Market Cap $55.1M
  • Description
  • CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...
More about CLGN
Track This Portfolio

Track Villere St Denis J & CO LLC Portfolio

Follow Villere St Denis J & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Villere St Denis J & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Villere St Denis J & CO LLC with notifications on news.